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To the Editor: 
 
We read with interest the article by Chen et al.1 However, we have concerns about the 
underlying premise of this study and, in particular, the conclusions. Although the authors 
describe US and European antibiotic prophylaxis (AP) guidelines, they give no details about 
the guidelines that apply in Taiwan. We assume that they are similar to the American Heart 
Association guidelines.2 However, the authors say that those with rheumatic heart disease are 
high-risk, suggesting that Taiwanese guidelines maybe more like those in Japan, where those 
at high risk and moderate risk of infective endocarditis (IE) are recommended for AP. It is 
disappointing the authors do not say which patients were considered high risk or provide the 
International Classification of Disease, Ninth Revision codes used to identify them. 
Similarly, they fail to say which International Classification of Disease, Ninth Revision codes 
were used to identify patients with IE, if they only included those with a primary IE 
diagnosis, or if they also included those with a secondary IE diagnosis. Such information is 
important LQ³ELJGDWD´VWXGLHV 
 
Far more important, however, one would expect that any link between invasive dental 
treatments and IE would be hidden or reduced in a setting where AP is the standard of care, if 
AP has any efficacy. The FRQFOXVLRQWKDW³:HDOVRIRXQGQR association between invasive 
dental treatments and IE among high-ULVNSDWLHQWV´ is not, therefore, supported by the study 
because any association could have been reduced or hidden by the use of AP. Furthermore, 
the concluVLRQ³7KHUHIRUHDQWLELRWLF SURSK\OD[LVIRUSUHYHQWLRQRI,(LVQRWUHTXLUHG´LV
unsupported by the results and potentially dangerous. Surely, in a country where those at risk 
of IE receive AP, the absence of any association between invasive dental treatments and IE is 
just as likely, arguably more likely, to prove that AP is effective in preventing IE. It is 
surprising that the authors make no mention of this and that it was not raised as a problem 
during the review process. 
 
They authors may be correct that AP is not effective, but their study does not provide the 
evidence to draw that conclusion. 
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